◀ Back to MMP7
CD44 — MMP7
Pathways - manually collected, often from reviews:
-
Reactome Reaction:
CD44
→
MMP7
(reaction)
Ahmed et al., Carcinogenesis 2002*, Samanna et al., Exp Cell Res 2006*, Toole et al., Curr Opin Cell Biol 1990*
-
Reactome Reaction:
CD44
→
MMP7
(direct_complex)
Ahmed et al., Carcinogenesis 2002*, Samanna et al., Exp Cell Res 2006*, Toole et al., Curr Opin Cell Biol 1990*
-
WikiPathways Wnt Signaling Pathway and Pluripotency:
EP300
→
Complex of 11 proteins
(activation)
-
WikiPathways Wnt Signaling Pathway and Pluripotency:
ZBTB33
→
Complex of 11 proteins
(mim-inhibition)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Huh et al., J Cell Biochem 2007
:
Both
CD44v6 and its ectodomain cleavage products were detected from ED 5 to ED 14, and a broad-spectrum
MMP inhibitor
blocked ectodomain cleavage in cultured stromal cells
Campo et al., Biochim Biophys Acta 2009
:
HA treatment produced different effects : low MW HA up-regulated
CD44 expression, increased PKCdelta and PKCepsilon levels, and
enhanced inflammation in untreated chondrocytes ; while in PMA treated cells it increased CD44, PKCdelta, PKCepsilon, NF-kB, TNF-alpha, IL-1beta,
MMP-13 , and iNOS expression and enhanced the effects of PMA ; medium MW HA did not exert action ; high MW HA had no effect on untreated chondrocytes ; however, it reduced PKCdelta, PKCepsilon, NF-kB activation and inflammation in PMA stimulated cells